Related Experiment Videos
Adverse reactions to iodinated contrast media
1Department of Diagnostic Imaging, Northern General Hospital NHS Trust, Sheffield, UK. MorcSK2@aol.com
European Radiology
|July 27, 2001
Summary
Adverse reactions to iodinated contrast media (ICM) are less common with low-osmolality agents. Prompt recognition and management of side effects are crucial for patient safety.
Area of Science:
- Radiology
- Pharmacology
Background:
- Adverse reactions to iodinated contrast media (ICM) are a significant concern in medical imaging.
- Patient factors like asthma, allergies, and instability increase reaction risk.
- Reactions are categorized as renal or general (acute/delayed), with varying severity.
Purpose of the Study:
- To review the types and risk factors for adverse reactions to ICM.
- To discuss strategies for minimizing contrast-media-induced renal impairment.
- To highlight precautions for diabetic patients on metformin.
Main Methods:
- Literature review of adverse reactions to iodinated contrast media.
- Analysis of risk factors and patient subgroups.
- Evaluation of preventative and management strategies.
Main Results:
- Low-osmolality ICM agents have reduced non-fatal reactions.
- Prompt recognition and treatment of acute reactions are vital.
- Low-osmolality agents and volume expansion reduce renal impairment.
- Care is needed with ICM in diabetic patients on metformin, especially those with nephropathy.
Conclusions:
- Minimizing ICM reactions involves using appropriate agents and patient selection.
- Effective management of acute reactions and prevention of renal impairment are key.
- Awareness of specific drug interactions, like metformin, is essential for patient safety.